Ernexa Therapeutics

(NASDAQ) ERNA

Current Price$11.99

Market Cap$13.98M

Since IPO (2021)-100%

5 Year-100%

1 Year-86%

1 Month+147%

Ernexa Therapeutics Financials at a Glance

Market Cap

$13.98M

Revenue (TTM)

$0.00

Net Income (TTM)

$11.39M

EPS (TTM)

$-30.72

P/E Ratio

-0.39

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$11.99

Volume

83,906

Open

$12.21

Price

$11.99

Volume

83,906

Open

$12.21

Previous Close

$11.99

Daily Range

$11.50 - $12.67

52-Week Range

$3.18 - $91.54

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$11.99

Volume

83,906

Open

$12.21

Previous Close

$11.99

Daily Range

$11.50 - $12.67

52-Week Range

$3.18 - $91.54

ERNA News

A researcher studying a sample in a petri dish

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ernexa Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Sanjeev Luther, MBA

Website

www.ernexatx.com

Headquarters

Cambridge, MA 92121, US

ERNA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-2505%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-2.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.98M

Shares Outstanding

1.17M

Volume

83.91K

Avg. Volume

1.60M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.32M

EBITDA

$13.84M

Operating Cash Flow

$7.02M

Capital Expenditure

$37.00K

Free Cash Flow

$7.05M

Cash & ST Invst.

$1.88M

Total Debt

$490.00K

Ernexa Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$86.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$13.98M

N/A

Market Cap/Employee

$2.33M

N/A

Employees

N/A

Net Income

$5.51M

+32.9%

EBITDA

$3.46M

-30.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$8.79M

+1011.6%

Accounts Receivable

$95.00K

-39.1%

Inventory

$0.00

N/A

Long Term Debt

$226.00K

-46.1%

Short Term Debt

$163.00K

-93.4%

Return on Assets

-1.08%

N/A

Return on Invested Capital

-1.43%

N/A

Free Cash Flow

$2.27M

-9.7%

Operating Cash Flow

$2.26M

-9.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PMNProMIS Neurosciences, Inc.

PMNProMIS Neurosciences, Inc.$10.98+1.67%

OSRHOSR Holdings, Inc.

OSRHOSR Holdings, Inc.$0.50-1.59%

LNAILunai Bioworks Inc.

LNAILunai Bioworks Inc.$2.26-2.62%

MPLTMapLight Therapeutics, Inc.

MPLTMapLight Therapeutics, Inc.$28.75-1.81%

DWTXDogwood Therapeutics, Inc.

DWTXDogwood Therapeutics, Inc.$1.79-1.10%

MBRXMoleculin Biotech, Inc.

MBRXMoleculin Biotech, Inc.$2.39+0.00%

AEMDAethlon Medical, Inc.

AEMDAethlon Medical, Inc.$2.20+4.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$215.33-0.02%

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

Questions About ERNA

What is the current price of Ernexa Therapeutics?

Ernexa Therapeutics is trading at $11.99 per share.

What is the 52-week range for Ernexa Therapeutics?

Over the past 52 weeks, Ernexa Therapeutics has traded between $3.18 and $91.54.

How much debt does Ernexa Therapeutics have?

As of the most recent reporting period, Ernexa Therapeutics reported total debt of $389,000.

How much cash does Ernexa Therapeutics have on hand?

Ernexa Therapeutics reported $9.18M in cash and cash equivalents in its most recent financial results.

What is Ernexa Therapeutics’s dividend yield?

Ernexa Therapeutics does not currently have a dividend yield.

Ernexa Therapeutics

Ernexa Therapeutics Financials at a Glance

ERNA News

Why Brooklyn ImmunoTherapeutics Crushed the Market Today

Why Brooklyn ImmunoTherapeutics Stock Crushed It in April

Up 1,300% in the Past Month, Is This Mysterious Biotech a Buy?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ernexa Therapeutics

ERNA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ernexa Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ERNA

What is the current price of Ernexa Therapeutics?

What is the 52-week range for Ernexa Therapeutics?

How much debt does Ernexa Therapeutics have?

How much cash does Ernexa Therapeutics have on hand?

What is Ernexa Therapeutics’s dividend yield?

Premium Investing Services